Valeant Pharmaceuticals, which owns a Rochester company with a long history in this area, will be adopting some of that heritage.

The Canadian pharmaceutical company that owns Bausch + Lomb will change its name to Bausch Health Companies effective in July.

The Fed decided last week to raise interest rates, we asked an RIT economist about who might feel the effects of that right away.

Also, a major investor in Valeant decided to sell his shares in the company, George Conboy of Brighton Securities ponders what that might mean for the future of B + L going forward.

The WXXI Business report looks at business and economic issues facing the Rochester area including Western New York and the Finger Lakes.